Wakamoto Pharmaceutical Co.,Ltd. (4512.T) JPX

Currency In JPY

AD

Valuation

Market Cap12.18B
Enterprise Value10.58B
P/E Ratio30.12
PEG Ratio0.02
Price/Sales Ratio1.01
Price/Book Ratio0.88
Enterprise/Revenue0.86
Enterprise/EBITDA12.51

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue9.91B
Revenue/Share292.86
Gross Profit4.73B
EBITDA701.22M
Net Income227.22M
Diluted EPS6.55

Balance Sheet

Total Cash1.92B
Total Cash/Share55.25
Total Debt400M
Total Debt/Equity0.03
Current Ratio3.79
Book Value Per Share337.66

Price History

52-Week Change1.71
52-Week High380
52-Week Low240
Moving Average 50 Days297.46
Moving Average 200 Days305.49

Statistics

Average Volume41,439
Shares Outstanding34.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.5
Trailing Annual Dividend Yield1.18
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD